AstraZeneca announces contest among biopharm scientists
5 Mar '12
Innovative biopharmaceutical company AstraZeneca has announced a contest for scientists, carrying research in sectors of Chemistry, Biology, Pharmacology and Medicine, innovation and venture news source UNOVA reports.
The contest “Avangard Znaniy” reportedly aims at motivating young scientists and discovering ideas that can be commercialized into business.
The winners will receive $1,500 prizes and opportunities to work in partnership with leading development institutes, such as the Russian Venture Company, RUSNANO, and Skolkovo.
“Avangard Znaniy” was first held in 2011, when it received 85 applications. This year the list was expanded to include projects in fields of oncology and cardiology, as well as infection diseases treatments, and new methods of scientific research.
Pharmaceutical company AstraZeneca was founded in 1999 as a result of the merger between Russian subsidiaries of Swedish company AstraAB and British Zeneca. In 2011 the company announced the plans of localization of production in Russia in order to make innovative medicines more available for Russian patients. The company is to build a full-cycle pharmaceutical plant in Kaluga region.